Keith Anthony Jones, Director at Humacyte, Inc. (HUMA), bought 30,000 shares at $0.59 ($18K) on 2026-08-17, disclosed to the SEC on 2026-08-19.
Director Keith Anthony Jones purchased $17,820 worth of Humacyte stock at $0.59 per share, marking the largest insider purchase in the company's history. This significant buy signals confidence in the company's clinical pipeline despite recent stock volatility.
The stock has crashed 63.64% over the last year and is currently trading 77.25% below its 52-week high of $2.55, while remaining 10.22% above the 52-week low of $0.5262.
Something here stands out, but not much.
| Filing → |